Asthma Control and Asthma Medication Use among Swedish Elite Endurance Athletes
Table 2
Level and distribution of asthma control in Swedish endurance athletes with current asthma.
Uncontrolled
Partially controlled
Well controlled
value
Female sex
11 (58)
17 (71)
32 (54)
0.378
Age (years), mean (SD)
19.8 (3.7)
21.3 (4.2)
22.2 (4.8)
0.174
Age of asthma onset (years), mean (SD)
13.4 (4.3)
16.5 (4.0)
12.1 (4.8)
0.009
Allergy
9 (47)
14 (58)
23 (44)
0.517
Training (hours/week), mean (SD)
12.9 (2.7)
13.1 (3.8)
11.1 (4.8)
0.855
Shortness of breath1
8 (42)
7 (29)
10 (17)
0.079
Health care contacts2
9 (47)
8 (33)
7 (12)
0.003
Family history of asthma
12 (63)
13 (62)
37 (69)
0.828
Daily SABA/LABA
14 (74)
12 (50)
15 (25)
<0.001
Daily ICS
9 (47)
7 (29)
18 (31)
0.353
Daily ICS + LABA
10 (53)
8 (33)
13 (22)
0.039
The data are presented as n (%) unless otherwise stated; significant values are shown in bold; 1shortness of breath following strenuous exercise in the previous 12 months; 2respiratory-related health care contacts in the previous 12 months; ICS, inhaled corticosteroids; SABA/LABA, short-acting β2-agonists/long-acting β2-agonists; SD, standard deviation; Pearson’s chi-squared test.
